BlackRock Investment Management’s Zosano Pharma Corporation ZSAN Stock Holding History

BlackRock Investment Management’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1	Closed	-$2K	–	4164
2016 Q1	$2K	Hold	1	–	–	﹤0.01%	3991
2015 Q4	$2K	Hold	1	–	–	﹤0.01%	4032
2015 Q3	$3K	Hold	1	–	–	﹤0.01%	4046
2015 Q2	$6K	Hold	1	–	–	﹤0.01%	3920
2015 Q1	$6K	Buy	+1	New	+$7.5K	﹤0.01%	3824

Other funds holding ZSAN

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

LOAMU

Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BlackRock Investment Management's ZSAN Position: Q2 2016 in Review

BlackRock Investment Management sold out of Zosano Pharma Corporation (ZSAN) in Q2 2016, closing a stake of 1 share — an estimated $2K sold.

BlackRock Investment Management first reported a position in ZSAN in Q1 2015 and held it in 5 quarters. The position peaked at $6K in Q2 2015. 11 funds tracked by Wall St. Rank hold ZSAN as of Q2 2016.

BlackRock Investment Management reported no remaining Zosano Pharma Corporation position as of Q2 2016 after selling out during the quarter.
BlackRock Investment Management sold 1 Zosano Pharma Corporation share in Q2 2016, an estimated $2K.
BlackRock Investment Management first reported a position in Zosano Pharma Corporation in Q1 2015 and held it in 5 quarters.
BlackRock Investment Management's Zosano Pharma Corporation position peaked at $6K in Q2 2015.
11 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2016.

Based on BlackRock Investment Management's 13F filing for Q2 2016, filed 10 Aug 2016.